Value proposition

Discovering drugs using highly customized human tissues as living, dynamic models of human biology and disease.

We are pioneering a unique set of therapeutic and drug profiling capabilities based on our revolutionary ability to 3D bioprint tissues that mimic key aspects of human biology and disease. We intend to fundamentally alter the drug discovery landscape by the development of novel therapies for disease which have a much higher chance of efficacy in the clinic focused on human primary cell 3D models of disease that more faithfully recapitulate disease processes. Learn more at www.organovo.com.

3D bioprinting, 3D printing, Drug discovery and development, Human disease research, and Human disease models